NYSE · Healthcare · Healthcare Plans · USA
Humana Inc is a large cap company (market value between $10 billion and $200 billion) in the Healthcare Plans industry.
Humana Inc provides health insurance and healthcare services through two segments: Insurance and CenterWell. The Insurance segment offers medical and specialty insurance products, including Medicare Advantage plans, prescription drug plans, and state-based contracts, serving Medicare and Medicaid beneficiaries, families, and individuals. The company also operates a pharmacy benefit manager business.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Humana Inc stock.
Slightly overvalued: intrinsic value $357.63 per share, market price $414.98, margin of safety -16.0% (as of 2026-10-19).
Discounting its cash flows at 8.1% (average of 3 methods) values the shares at $357.63; the price of $414.98 is 16% above that value, and 79% of that value comes from beyond year five.
Leak Score: 33/100 on 12 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 11 Healthcare Plans stocks
HUM is slightly overvalued (as of the 2026-10-19 close). Discounting its cash flows at 8.1% (average of 3 methods) values the shares at $357.63; the price of $414.98 is 16% above that value, and 79% of that value comes from beyond year five.
$357.63 per share (as of the 2026-10-19 close), against a market price of $414.98. That is a margin of safety of -16.0%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
33 out of 100, which we rate "On Watch", on 12 of 12 value investing signals.